BioTime, a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, and its majority-owned subsidiary, Cell Cure Neurosciences, have dedicated a new, 800 square-meter, state-of-the-art, cGMP manufacturing center located in the Jerusalem Bio Park on the campus of Hadassah University Hospital in Jerusalem. The new manufacturing center, initially to be staffed by 25-30 employees, is equipped to produce a range of cell therapies for the treatm...